
Dr. Reddy's gets ₹27 lakh penalty from Mexican drug regulator
The Hindu
Dr. Reddy's Laboratories fined ₹27 lakh by Mexico's drug regulator for import filing deviation. Trading down 0.70%.
Dr. Reddy's Laboratories on Thursday (November 14, 2024) said Mexico's drug regulator has imposed a fine of ₹27 lakh on it for deviation from prescribed guidelines in filing intimation of import for a product.
The drug regulatory body of Mexico has imposed a penalty of ₹27 lakh on the company for deviation from prescribed guidelines in filing intimation of import of a reference standard for one of the APIs, the Hyderabad-based firm said in a regulatory filing.
Additionally, the fine was imposed due to an error in the date of the invoice and also in the name of the reference standard versus import license, it added.
Shares of Dr. Reddy's Laboratories were trading 0.70% down at ₹1,237 apiece on BSE.

In a surprising turn of events, Urvashi theatre, one of Bengaluru’s iconic single screens, has re-opened, with the much-talked-about Dhurandhar: The Revenge running to a full house in the theatre. After the expiry of the 45-year lease, it seemed like curtains would come down on the king-size theatre but for now, it’s good news for fans.












